Hepatic Encephalopathy Severity and Mortality Risk Stratification in Alcohol-Related Acute-on-Chronic Liver Failure
Tijana Glisic, Bojan Korica, Branko Beronja, Milica Djakovic, Nevena Baljosevic, Dusan Dj Popovic, Jelena Martinov Nestorov, Milica Stojkovic Lalosevic · 2026
Read Hepatic Encephalopathy Severity and Mortality Risk Stratification in Alcohol-Related Acute-on-Chronic Liver Failure by Tijana Glisic, Bojan Korica, Branko Beronja, Milica Djakovic, Nevena Baljosevic, Dusan Dj Popovic, Jelena Martinov Nestorov, Milica Stojkovic Lalosevic (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13256075.txt.
Introduction
Glisic and colleagues asked whether the depth of hepatic encephalopathy on arrival predicts short-term death in alcohol-related acute-on-chronic liver failure. One hundred intensive care patients with both conditions were graded with the West Haven criteria and followed for hospital outcomes. Standard organ failure and physiology scores were compared between lower and higher encephalopathy grades.
Patients with higher-grade encephalopathy stayed longer in hospital and died more often within seven and twenty-eight days. Their organ failure scores were also significantly worse, and survival curves separated clearly. Acute kidney injury tracked with mortality in both grade groups. The authors support encephalopathy grade as a practical risk stratification tool.
Catalog record
| CREATOR | Tijana Glisic, Bojan Korica, Branko Beronja, Milica Djakovic, Nevena Baljosevic, Dusan Dj Popovic, Jelena Martinov Nestorov, Milica Stojkovic Lalosevic |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Hepatic Encephalopathy Severity and Mortality Risk Stratification in Alcohol-Related Acute-on-Chronic Liver Failure Authors: Tijana Glisic, Bojan Korica, Branko Beronja, Milica Djakovic, Nevena Baljosevic, Dusan Dj Popovic, Jelena Martinov Nestorov, Milica Stojkovic Lalosevic Published: 2026 ABSTRACT Background/Objectives: Acute-on-chronic liver failure (ACLF) is characterized by multiple organ failure and short-term mortality, and hepatic encephalopathy (HE) is its frequent complication. We investigated whether the severity of HE upon admission in patients with alcohol-related ACLF at the intensive care unit (ICU) was associated with short-term mortality. Methods: In total, 100 patients with alcohol-related ACLF and HE admitted in ICU were enrolled in the study. Laboratory biomarkers, total hospital length of stay (LOS), ICU length of stay, acute kidney injury (AKI), Acute Physiology and Chronic Health Evaluation II score, CLIF-C organ failure and Sequential Organ Failure Assessment score were tested in relation to the mortality risk. HE was assessed and divided into groups using the West Haven criteria. Results: Total hospital LOS, 7-day and 28-day mortality were significantly higher in the higher-grade HE group (p = 0.035, p = 0.031, p = 0.002, respectively). CLIF-C OF, SOFA, and APACHE II scores were significantly higher in the higher-grade HE group (p < 0.001). Kaplan–Meier survival analysis demonstrated reduced survival in patients with higher-grade HE (log-rank p < 0.001). In Cox regression analyses, AKI was associated with short-term mortality in both HE groups. Total hospital LOS and ICU length of stay were also associated with mortality, but were interpreted as post-baseline markers of clinical trajectory rather than baseline prognostic predictors. Conclusions: In patients with alcohol-related ACLF and HE, higher-grade HE was associated with poorer short-term survival. AKI and higher CLIF-C OF, SOFA and APACHE II scores were associated with poor outcomes, supporting their clinical relevance for mortality risk stratification in this population. LOS-related findings should be interpreted as markers of clinical trajectory rather than baseline prognostic predictors. 1. Introduction Acute-on-chronic liver failure (ACLF) is a distinct clinical syndrome that occurs in the setting of chronic liver disease and is characterized by acute liver failure associated with organ dysfunction and high short-term mortality [1,2,3]. According to the number of organ failure (OF), ACLF is classified from grade 1 (less sever) to grade 3 (most sever). The high mortality observed in patients with ACLF treated in intensive care units (ICUs) is closely associated with multiple organ dysfunction [1]. It is important to emphasize that the type of organ(s), and not just the number of organs involved in ACLF, has a significant impact on mortality. Hepatic encephalopathy (HE) and renal failure, in particular, have been associated with high short-term mortality (28 days) [4,5]. Worldwide, the prevalence of ACLF is about 35% among those with decompensated cirrhosis, with the highest incidence in South Asia, estimated at 65%. The 90-day mortality rate can reach 58% to 68% in South Asia [6]. Hepatic encephalopathy (HE) is a frequent and challenging complication of chronic liver disease, particularly in patients with ACLF, with reported prevalence ranging from 17.2% to 57.8% [7,8]. HE is a major cause of ICU admission and is associated with high mortality in this population. Its multifactorial pathogenesis makes prediction and risk stratification difficult. HE severity is commonly assessed using the West Haven criteria, which classify patients according to changes in behavior and level of consciousness [9,10]. Several laboratory markers and prognostic models, including ammonia, MELD, MELD-Na and inflammatory indices, have been evaluated for HE prediction and outcome assessment [11,12,13,14]. In patients with ACLF, broader severity scores such as APACHE II and SOFA may be useful because they capture multiorgan dysfunction and critical illness severity [15,16,17]. Previous studies have shown that HE in ACLF is associated with increased mortality, particularly in patients with higher HE grades [18,19]. A significant factor contributing to the poor outcome of patients with ACLF is the development of infection. In these patients, infections are recognized as an independent risk factor for mortality, with rates reaching up to 70% within 30 days. Therefore, early recognition of infection and its prompt treatment are paramount for patient outcome [20,21,22]. The synergistic interplay of the systemic inflammation which exists in chronic liver disease and infection has been recognized as fundamental in the development and progression of hepatic encephalopathy. Proinflammatory cytokines activate cerebral endothelial cells and circulating immune cells can then adhere to the activated endothelium and be recruited by the brain parenchyma. As a result, activation of microglia and astrocyte occurs [23]. These immune cells then produce proinflammatory cytokines, propagating neuroinflammation and altering neurotransmission and behavior [24]. Additionally, in acute liver failure, neutrophils have reduced phagocytic activity, increasing susceptibility to bacterial infection [25,26]. The aim of our retrospective study was to evaluate whether the severity of hepatic encephalopathy upon admission in patients with ACLF at the intensive care unit is associated with in-hospital short-term mortality. Furthermore, we sought to identify the risk factors associated with severity of HE and short-term mortality. 2. Materials and Methods 2.1. Study Design and Patient Population This retrospective cohort study included patients with acute-on-chronic liver failure (ACLF) admitted to the hepatology intensive care unit (ICU) of the Emergency Centre, University Clinical Centre of Serbia, a tertiary referral and the largest national center for the management of severe liver disease, between January 2020 and March 2025. A total of 100 patients with ACLF due exclusively to alcoholic liver disease were included. Patients were selected from the overall ACLF population treated at our institution during the study period, and only those with alcohol-related ACLF (“alcohol-on-alcohol ACLF”) were analyzed. The diagnosis of advanced chronic liver disease was based on relevant clinical findings, laboratory parameters, imaging methods including ultrasonography and/or computed tomography, and/or histological reports. All patients required ICU admission at presentation due to the severity of their condition, while a proportion of patients were subsequently transferred to standard hospital wards after clinical stabilization. Exclusion criteria included age below 18 years, presence of malignancy, prior liver or splenic surgery, previous transjugular intrahepatic portosystemic shunt placement, portal vein thrombosis, use of immunosuppressive therapy, and human immunodeficiency virus infection. 2.2. Definitions and Data Collection The diagnosis of ACLF was established in accordance with the criteria of the European Association for the Study of the Liver–Chronic Liver Failure Consortium (EASL-CLIF) [1]. Organ failure was assessed using the CLIF-C organ failure (CLIF-C OF) score, which evaluates six organ systems including liver, kidney, brain, coagulation, circulation, and respiration, and ACLF severity was graded based on the number and type of organ failures [27]. Hepatic encephalopathy (HE) severity was graded at ICU admission according to the West Haven criteria [10] by an experienced gastroenterologist/hepatologist, based on bedside assessment of mental status, orientation, behavior, psychomotor function, neuromuscular signs and level of consciousness. Patients with West Haven grades I–II were categorized as lower-grade HE, whereas patients with grades III–IV were categorized as higher-grade HE. This classification represented the primary exposure variable for subsequent analyses. Clinical and laboratory data were collected from electronic and written medical records at the time of ICU admission. Demographic and clinical variables included age, sex, presence of ascites, hepatic encephalopathy grade, history of prior liver-related hospitalizations, and comorbidities such as arterial hypertension, diabetes mellitus, cardiovascular diseases, chronic pulmonary diseases and chronic kidney diseases. Laboratory parameters included complete blood count with differential (red blood cells,